Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Not yet recruiting 2Withdrawn 1Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 2Endocrine 1

Conditions

Thyroid Neoplasms 2Thyroid Diseases 1Thyroid Cancer, Papillary 1Advanced Differentiated Thyroid Gland Carcinoma 1

Interventions

trametinib 2anlotinib 2Thyroxine 2Surgical Procedures, Operative 2sintilimab 1selpercatinib 1pralsetinib 1pembrolizumab 1lenvatinib 1larotrectinib 1dabrafenib 1cabozantinib 1Vindesine 1Triiodothyronine 1TP protocol 1Radiofrequency Ablation 1Paclitaxel 1Gemcitabine 1Doxorubicin 1Docetaxel 1Decision Support Techniques 1Cyclophosphamide 1Conversion to Open Surgery 1Cisplatin 1CP protocol 1Bariatric Surgery 1(177)Lu-DOTA-EB-TATE 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Thyroid Neoplasms × Thyroxine × Clear all
NCT06647602 2026-02-10

THRIVE

University Medical Center Groningen

Not yet recruiting
40 enrolled
Head & Neck

Thyroid Neoplasms

NCT06971965 2025-05-14

MAeSTro-TSH

National Cancer Center, Korea

Phase NA Not yet recruiting
578 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡